Kristian Reich
71PUBLICATIONS
116CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (71)
Sort by Publication Date:
|Feb 05, 2026
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND.Andrew Blauvelt, H Chih-Ho Hong, Norito Katoh
|Nov 11, 2025
Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis.Melinda Gooderham, Mahreen Ameen, H Chih-Ho Hong
|Aug 29, 2025
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials.Kristian Reich, Richard G Langley, Juan Francisco Silvestre Salvador
|Feb 15, 2025
Efficacy and safety of mirikizumab in psoriasis: a systematic review and meta-analysis of randomized controlled trials.Mable Pereira, Ancy Jenil Franco, Karthik Chintharala
|May 20, 2024
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries.María José Valencia López, Brigitte Stephan, Anna Meineke
|Feb 01, 2024
Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA).Kristian Reich, Luca Bianchi, Abdallah Khemis
Pageof 12
Frequent Collaborators
15 joint publications
Matthias Augustin
14 joint publications
Andrew Blauvelt
9 joint publications
Ulrich Mrowietz
8 joint publications
Kim Papp
7 joint publications
Carle Paul
6 joint publications
Jonathan I Silverberg
6 joint publications
April W Armstrong
5 joint publications
L Puig
4 joint publications
Andreas Pinter
4 joint publications
Peter Foley
